A Blueprint for Pharmacy Benefits Managers to Increase Value

William  Shrank; Michael E. Porter; Sachin H. Jain; Niteesh K. Choudhary

Article | American Journal of Managed Care

A Blueprint for Pharmacy Benefits Managers to Increase Value

by William Shrank, Michael E. Porter, Sachin H. Jain and Niteesh K. Choudhary

Abstract

Pharmacy benefits managers (PBMs) have a unique opportunity to promote public health and generate value in the healthcare system. However, PBMs are largely evaluated on their ability to control costs rather than improve health. PBMs should be evaluated along three dimensions in which they can increase value: 1) the use of cost-effective medications, 2) the timely initiation of appropriate medications, and 3) adherence to those medications. Value promotion requires the development of integrated data systems, stronger partnerships with patients and physicians and improved measurement and reporting of results. Incentives for PBMs to promote value should drive innovation and improve health outcomes.

Keywords: Opportunities; Health; System; Cost Management; Partners and Partnerships; Motivation and Incentives; Value; Innovation and Invention; Performance Effectiveness; Health Industry; Pharmaceutical Industry;

Format: Print

Find at Harvard

Citation:

Shrank, William, Michael E. Porter, Sachin H. Jain, and Niteesh K. Choudhary. "A Blueprint for Pharmacy Benefits Managers to Increase Value." American Journal of Managed Care 15, no. 2 (February 2009).

Since its establishment in 2005, Hamburg’s Martini Klinik had single-mindedly focused on prostate cancer care with a commitment to measure long term health outcomes for every patient. A wholly owned subsidiary of the University Hospital Hamburg, Martini Klinik was a “hospital in a hospital” in close proximity to other medical departments and services. By 2019, Martini Klinik had become the largest prostate cancer treatment program in the world with 8,000 outpatient cases and more than 2,500 surgical cases annually. Patients came from all over Germany and from around the world. A new and expanded facility was under construction to have the capacity to manage more patients with prostate cancer.

We are entering a new stage of understanding of the linkage between investment performance and social impact. Previous approaches, such as socially responsible investing and environmental, social, and governance (ESG) screening, have obscured the opportunities for higher growth, profitability, and competitive advantage that come from creating shared value: addressing social and environmental issues as integral to a company’s core strategic positioning. A shared value approach to investing can deliver superior shareholder returns, but capturing that value will require very different practices on the part of both corporate leaders and investors.

Faculty & Research

A Blueprint for Pharmacy Benefits Managers to Increase Value

Abstract

Citation:

About the Author

More from the Author